Skip to main content
OpenTrials
Completed

NCT Number: NCT03520270

Prevalence of Potentially Inappropriate Treatments

A multicenter point prevalence study in Turkish intensive care units.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul University Cerrahpasa Medical School

Istanbul, Turkey (Türkiye)

About this study

Intensive care units (ICU) are life-saving units for critical patients with using advanced technology. In some cases, it becomes a unit where treatment is not possible, the fatal patients are admitted and the death process is extended. Most patients with end-stage cancer, advanced-stage chronic obstructive pulmonary disease (COPD) and advanced-stage Alzheimer's disease prefer to die at home, although many often refer to emergency services at the end of their life and are then transferred to the ICU. Intensive care treatments are often very invasive and painful interventions. The patient who lives in intensive care unit is faced with many psychological distresses such as communication, isolation and fear besides physical ache. For this reason, it is necessary to make decisions (end-of-life decisions) such as forbearing intensive care treatments applied to the patients in the death process or cutting out the ones started. In the world, the goal for the end of life patients is, improving the last phase of their lives with the application of these decisions and symptom therapy, living in a peace without pain and respiratory distress. However, there is an uncertanity in these issues in our country and intensive care physicians are hesitant to make decisions about the end of life with concern about legal problems. Although it is known that these patients will not benefit most from the treatment of ICU, they are getting treatments for saving their lives in ICUs. The fact that intensive care beds are not available due to the patients who are not get beneficial treatment, brings the result of difficult finding of the beds which will benefit from the intensive care, and in fact it is a waste of intensive care resources which is very expensive. The size of the problem is not known as there is no data on the frequency of patients in our country who are in intensive care and require end-of-life care.

In this multicenter point prevalence study our aims are;

  • to find out the incidence of patients in intensive care units in Turkey in the last period of life,
  • to compare the resource use of end-of-life and non-end-of-life patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients who are over 18 years old, more than 48 hours in the intensive care unit, or expected to be hospitalized

Exclusion criteria

Patients under 18 years of age, less than 48 hours in the intensive care unit stay, or who are monitorized for post-operative care

Treatment and study plan

Primary outcomes

  1. Prevalence of terminal patients in the ICU

    Time frame: 1 day

    Investigation of the number of terminal patients treated in the intensive care units at the last days of life

Secondary outcomes

  1. Resource use

    Time frame: 1 day

    Comparison of treatment implementations such as antibiotics, use of mechanical ventilation, renal replacement therapy, nutrition and blood transfusions and their estimated costs, used for terminal and non-terminal patients

Sponsors and collaborators

Lead sponsor

Istanbul University

Other

Registry information

Official study title

Potentially Inappropriate Treatments in Turkish ICUs: Point Prevalence Study

Acronym: INAPPT-ICU

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
May 9, 2018
Registry last updated
Mar 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.